[YIA-1]Neuroblastoma suppressor of tumorigenicity 1(NBL1)and risk of progression to end-stage kidney disease(ESKD)in diabetes
Hiroki Kobayashi(Division of Nephrology, Hypertension, and Endocrinology, Nihon University School of Medicine, Tokyo, Japan)
Password required to view
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.
Password is required to view the abstract. Please enter a password to authenticate.
